BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2010
View Archived Issues
Ad28-based adenovirus vector is strongly immunogenic
Read More
Daiichi Sankyo claims new Mdm2-p53 interaction inhibitors
Read More
German scientists disclose new inhibitors of tau aggregation
Read More
Italian researchers describe new antimicrobial agents
Read More
New tyrosine-protein kinase inhibitors claimed by sanofi-aventis
Read More
New alpha-mannosidase inhibitors identified by Emory University
Read More
Mission Pharmacal launches Uribel capsules for symptoms of urinary tract conditions in U.S.
Read More
Acrux issues update on female health products
Read More
QRxPharma reports encouraging phase II proof-of-concept data on MoxDuo IV
Read More
New models predict activity/selectivity of cannabinoid receptor agonists/antagonists
Read More
Clomipramine reduces GFAP levels in Alexander's disease model / News in Context
Read More
Pfizer describes MR antagonist for diabetic nephropathy
Read More
AM-643 is a candidate for topical treatment of skin disorders
Read More
Elan and Transition Therapeutics report phase II data on ELND-005 in Alzheimer's disease
Read More
FDA grants orphan drug status to CYT-387 for myelofibrosis
Read More
Fibrocell Science submits phase II/III Azficel-T trial report to FDA
Read More
ILLUMINATE trial supports 24-week telaprevir-based therapy in HCV infection
Read More
FDA grants priority review to rifaximin sNDA for non-constipation-predominant IBS
Read More
Scancell and Cancer Research Technology sign antibody license agreement
Read More
Teva Pharmaceutical acquires ratiopharm
Read More
Lentigen receives NIH grant to develop melanoma immunotherapy
Read More
Genmab presents phase II ofatumumab data in diffuse large B-cell lymphoma
Read More
Shire divests ADHD therapeutic Daytrana to Noven Pharma
Read More
NsGene and Biogen Idec sign new agreement for artemin
Read More
Advanced Life Sciences and FDA reach SPA agreement for phase III Restanza trial in pneumonia
Read More
